A citation-based method for searching scientific literature

Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011
Times Cited: 143



Nadine Tung, Susan M Domchek, Zsofia Stadler, Katherine L Nathanson, Fergus Couch, Judy E Garber, Kenneth Offit, Mark E Robson. Nat Rev Clin Oncol 2016
Times Cited: 153




List of shared articles



Times cited

Psychosocial Effects of Multigene Panel Testing in the Context of Cancer Genomics.
Jada G Hamilton, Mark E Robson. Hastings Cent Rep 2019
6

An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Carolyn Piccinin, Seema Panchal, Nicholas Watkins, Raymond H Kim. Expert Rev Anticancer Ther 2019
8

Understanding inherited risk in unselected newly diagnosed patients with endometrial cancer.
Karen A Cadoo, Diana L Mandelker, Semanti Mukherjee, Carolyn Stewart, Deborah DeLair, Vignesh Ravichandran, Preethi Srinivasan, Daire Hurley, Yelena Kemel, Angela G Arnold,[...]. JCO Precis Oncol 2019
1

Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.
Miriam Lobo, Sara López-Tarruella, Soledad Luque, Santiago Lizarraga, Carmen Flores-Sánchez, Oscar Bueno, Jesús Solera, Yolanda Jerez, Ricardo González Del Val, María Isabel Palomero,[...]. J Genet Couns 2018
3

Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
Allison H West, Kathleen R Blazer, Jessica Stoll, Matthew Jones, Caroline M Weipert, Sarah M Nielsen, Sonia S Kupfer, Jeffrey N Weitzel, Olufunmilayo I Olopade. Fam Cancer 2018
10

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.
Thomas P Slavin, Kara N Maxwell, Jenna Lilyquist, Joseph Vijai, Susan L Neuhausen, Steven N Hart, Vignesh Ravichandran, Tinu Thomas, Ann Maria, Danylo Villano,[...]. NPJ Breast Cancer 2017
66